These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27429192)

  • 1. Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.
    Singh JA
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S252-5. PubMed ID: 27429192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.
    Mayer KH; Grinsztejn B; El-Sadr WM
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S207-9. PubMed ID: 27429184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Exposure Prophylaxis in Trans Populations: Providing Gender-Affirming Prevention for Trans People at High Risk of Acquiring HIV.
    Deutsch MB
    LGBT Health; 2018 Oct; 5(7):387-390. PubMed ID: 30272493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related care for transgender people: A systematic review of studies from around the world.
    Vaitses Fontanari AM; Zanella GI; Feijó M; Churchill S; Rodrigues Lobato MI; Costa AB
    Soc Sci Med; 2019 Jun; 230():280-294. PubMed ID: 31035207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design Issues in Transgender Studies.
    Hughes JP; Emel L; Hanscom B; Zangeneh S
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S248-51. PubMed ID: 27429191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action.
    Poteat T; Malik M; Scheim A; Elliott A
    Curr HIV/AIDS Rep; 2017 Aug; 14(4):141-152. PubMed ID: 28752285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations for new HIV prevention trials.
    Sugarman J; Celum CL; Donnell D; Mayer KH
    Lancet HIV; 2019 Aug; 6(8):e489-e491. PubMed ID: 31221591
    [No Abstract]   [Full Text] [Related]  

  • 13. Disparities of HIV risk and PrEP use among transgender women of color in South Florida.
    Holder CL; Perez-Gilbe HR; Fajardo FJ; Garcia S; Cyrus E
    J Natl Med Assoc; 2019 Dec; 111(6):625-632. PubMed ID: 31526532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
    Grant RM; Sevelius JM; Guanira JV; Aguilar JV; Chariyalertsak S; Deutsch MB
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S226-9. PubMed ID: 27429187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
    Seekaew P; Nguyen E; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Nakorn PRN; Mills S; Avery M; Vannakit R; Phanuphak P; Phanuphak N
    BMC Public Health; 2019 Mar; 19(1):328. PubMed ID: 30898095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
    Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
    AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising HIV programming for transgender women in Brazil.
    Sevelius J; Murray LR; Martinez Fernandes N; Veras MA; Grinsztejn B; Lippman SA
    Cult Health Sex; 2019 May; 21(5):543-558. PubMed ID: 30378463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
    Hoagland B; De Boni RB; Moreira RI; Madruga JV; Kallas EG; Goulart SP; Cerqueira N; Torres TS; Luz PM; Fernandes NM; Liu AY; Grinsztejn B; Veloso VG;
    AIDS Behav; 2017 May; 21(5):1278-1287. PubMed ID: 27531461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking the Belmont Report?
    Friesen P; Kearns L; Redman B; Caplan AL
    Am J Bioeth; 2017 Jul; 17(7):15-21. PubMed ID: 28661753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
    Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
    AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.